Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01884844 · ClinicalTrials.gov registry record · NA

Vitamin D Supplementation for Bipolar Depression

A NA study of Bipolar Disorder and Bipolar Depression, sponsored by University of Massachusetts, Worcester.

Completed
Registry status
NA
Development phase
33
Enrollment target
2
Study locations

NCT01884844 is a NA study of Bipolar Disorder and Bipolar Depression that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 33 participants, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (90% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01884844, a NA study of Bipolar Disorder and Bipolar Depression, has completed, sponsored by University of Massachusetts, Worcester.

COMPLETED
Registry status
NA
Development phase
33 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to whether vitamin d supplementation in those with low levels may reduce depression symptoms in people experiencing bipolar depression.

Interventions

  • DRUG Placebo
  • DRUG Vitamin D3, Cholecalciferol

Study Locations (2)

Massachusetts

  • University of Massachusettes - Worcester
  • University of Massachusetts School of Medicine - Worcester

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2013-06
Est. Completion 2015-08
Phase NA

What the Registry Record Tells You About NCT01884844

The ClinicalTrials.gov registry entry for NCT01884844 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (90% lower). The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Bipolar Disorder appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT01884844 reports 2 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01884844 about?

NCT01884844 is a clinical study titled "Vitamin D Supplementation for Bipolar Depression". The purpose of this study is to whether vitamin d supplementation in those with low levels may reduce depression symptoms in people experiencing bipolar depression.

What is the current status of trial NCT01884844?

This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2013-06. Estimated completion is 2015-08.

What conditions does trial NCT01884844 study?

This clinical trial studies the following conditions: Bipolar Disorder, Bipolar Depression.

What interventions are being tested in trial NCT01884844?

The interventions under investigation include: Placebo (DRUG), Vitamin D3, Cholecalciferol (DRUG).

Who is sponsoring clinical trial NCT01884844?

This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01884844 being conducted?

This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bipolar Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.